Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 879.38% | 1,456.12% | 191.21% | -26.10% | -- |
| Gross Profit | 2,622.50% | 2,353.55% | -191.21% | 26.10% | -- |
| SG&A Expenses | 564.20% | 296.49% | 24.52% | 30.71% | 49.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 550.16% | 208.09% | 0.78% | -5.21% | 10.33% |
| Operating Income | -328.33% | -131.15% | -0.78% | 5.21% | -10.33% |
| Income Before Tax | -537.41% | -138.83% | 7.73% | 18.01% | -7.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -444.55% | -134.21% | 7.73% | 18.01% | -7.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -444.55% | -134.21% | 7.73% | 18.01% | -7.78% |
| EBIT | -328.33% | -131.15% | -0.78% | 5.21% | -10.33% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -41.78% | 45.85% | 65.85% | 74.96% | 72.23% |
| Normalized Basic EPS | -57.18% | 45.37% | 65.85% | 74.96% | 72.23% |
| EPS Diluted | -41.78% | 45.85% | 65.85% | 74.96% | 72.23% |
| Normalized Diluted EPS | -57.18% | 45.37% | 65.85% | 74.96% | 72.23% |
| Average Basic Shares Outstanding | 235.04% | 169.27% | 81.01% | 173.15% | 336.45% |
| Average Diluted Shares Outstanding | 235.04% | 169.27% | 81.01% | 173.15% | 336.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |